Pharmaceutical Wholesaler Agrees To $500,000 Settlement On Diverted Drugs

An Ohio pharmaceutical wholesaler, Masters Pharmaceutical, Inc, agreed to pay $500,000 and entered into a consent decree pertaining to compliance with DEA regulations in settlement of claims that the distributor unlawfully supplied controlled substances to unlawful internet pharmacies and failed to report those sales to the DEA.
The settlement agreement covers the sales of more than 4,199,465 dosage units of hydrocodone, phentermine and alprazolam that occurred between 2005 and 2008 and were not reported to the DEA. DEA has reporting requirements with respect to the theft or diversion of controlled substances under 21 C.F.R. 1301.74(b).
To read more, click here and here.